PTCT - PTC THERAPEUTICS, INC.

QQQ $ 454.82 $ -0.09 (-0.02 %)

DIA $ 398.57 $ -2.12 (-0.53 %)

SPY $ 530.36 $ -1.53 (-0.29 %)

TLT $ 91.26 $ 0.11 (0.12 %)

GLD $ 225.37 $ -4.12 (-1.84 %)

Previous Close

$ 38.64

Open

$ 39.38

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 37.30 - $ 39.38

52 Week Range

$ 17.53 - $ 59.75

Volume

1,085,656

Average Volume

Market Cap

2.96B

Beta (5Y Monthly)

$ 0.90

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-25-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	10-26-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	04-27-2023	03-31-2023	10-Q
6	02-21-2023	12-31-2022	10-K
7	10-27-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-03-2022	03-31-2022	10-Q
10	02-22-2022	12-31-2021	10-K
11	10-28-2021	09-30-2021	10-Q
12	07-29-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	10-29-2020	09-30-2020	10-Q
16	08-05-2020	06-30-2020	10-Q
17	04-30-2020	03-31-2020	10-Q
18	03-02-2020	12-31-2019	10-K
19	10-30-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-02-2019	03-31-2019	10-Q
22	03-01-2019	12-31-2018	10-K
23	11-05-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-06-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-08-2017	03-31-2017	10-Q
30	03-16-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	07-31-2015	06-30-2015	10-Q
37	05-05-2015	03-31-2015	10-Q
38	03-02-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Citigroup Maintains Sell on PTC Therapeuti...
05/21/2024 18:01:17

Citigroup analyst David Lebowitz maintains PTC Therapeutics (NASDAQ:PTCT) with a Sell and raises the price target from $18 t...

JP Morgan Maintains Overweight on PTC Ther...
05/21/2024 16:07:17

JP Morgan analyst Eric Joseph maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from $4...

Goldman Sachs Maintains Sell on PTC Therap...
05/21/2024 14:15:45

Goldman Sachs analyst Paul Choi maintains PTC Therapeutics (NASDAQ:PTCT) with a Sell and raises the price target from $18 to...

PTC Therapeutics Reports The European Comm...
05/21/2024 12:46:47

-Reuters

Jefferies Maintains Buy on PTC Therapeutic...
05/20/2024 17:35:16

Jefferies analyst Kelly Shi maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and raises the price target from $35 to $46.

why-virios-therapeutics-shares-are-trading-lower-by-around-48-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Virios Therapeutics Shares Are Trading...
05/20/2024 17:28:52

european-commission-requests-reevaluation-of-opinion-on-ptc-therapeutics-duchenne-dystrophy-drug-pauses-annual-guidance

European Commission Requests Reevaluation ...
05/20/2024 16:03:50

PTC Therapeutics announced that the European Commission has asked the CHMP to re-evaluate its negative opinion on the renewal o...

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday

Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

Market-Moving News for May 20th
05/20/2024 12:37:59

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation NKGN: 81% | NK...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
05/20/2024 12:06:50

PTC Therapeutics Paused 2024 Revenue Guida...
05/20/2024 11:07:09

Given the inability to accurately forecast the upside impact of the continued authorization of Translarna in Europe on 2024 rev...

PTC Therapeutics Announces European Commis...
05/20/2024 11:04:26

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the European Commission (EC) has decided not to adopt the CHMP's ...

PTC Therapeutics shares are trading higher...
05/14/2024 15:11:39

PTC Therapeutics Announces FDA Acceptance ...
05/14/2024 11:31:22

Morgan Stanley Upgrades PTC Therapeutics t...
04/29/2024 09:11:35

Morgan Stanley analyst Jeffrey Hung upgrades PTC Therapeutics (NASDAQ:PTCT) from Underweight to Equal-Weight and raises the ...

PTC Therapeutics Reaffirms FY24 Financial ...
04/25/2024 21:18:50

PTC Therapeutics Says On Target To Achieve...
04/25/2024 21:16:49

PTC Therapeutics Q1 2024 GAAP EPS $(1.20) ...
04/25/2024 20:39:10

PTC Therapeutics (NASDAQ:PTCT) reported quarterly losses of $(1.20) per share which beat the analyst consensus estimate of $(1....

Cantor Fitzgerald Reiterates Overweight on...
04/12/2024 13:55:08

Cantor Fitzgerald analyst Kristen Kluska reiterates PTC Therapeutics (NASDAQ:PTCT) with a Overweight and maintains $45 price...

PTC Therapeutics Submits Sepiapterin MAA F...
03/28/2024 12:34:14

- First marketing authorization submission for sepiapterin with additional global submissions to follow in 2024 -